Companies: 10,795·Total market cap: $144.5T
Dynavax Technologies Corporation

Dynavax Technologies Corporation

DVAXNASDAQHealthcare
$15.50
+$0.00(+0.00%)
Market Cap$1.8B
P/E Ratio
52W High$15.73
52W Low$9.2

Dynavax Technologies Corporation (DVAX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · DVAX · as of Feb 20, 2025

Latest filing snapshot

405
-3-0.74%vs prior year

Dynavax Technologies Corporation (DVAX) employee data is sourced from the annual SEC 10-K filing. As of 2024, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2024-12-31·Full-time · Global
Total Employees
405
Change (1Y)
-3
Growth % (1Y)
-0.74%
Revenue / Employee
$684.6K
Net Income / Employee
$67.4K
Market Cap
$1.8B

DVAX Employee Count

2003 – 2024 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2025-02-20405-3-0.74%
2024-02-22408+57+16.24%
2023-02-23351+40+12.86%
2022-02-28311+66+26.94%
2021-02-25245+14+6.06%
2020-03-11231-18-7.23%
2019-02-27249+57+29.69%
2018-03-08192-59-23.51%
2017-03-13251+17+7.26%
2016-03-08234+37+18.78%

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Drug Manufacturers - Specialty & Generic
#SymbolCompanyEmployees
#1
Evotec SE
EVO
Evotec SE
4,766
#2
Amphastar Pharmaceuticals, Inc.
AMPH
Amphastar Pharmaceuticals, Inc.
2,028
#3
Dynavax Technologies Corporation
DVAX
Dynavax Technologies CorporationYOU
405
#4
Harrow Health, Inc.
HROW
Harrow Health, Inc.
382
#5
Collegium Pharmaceutical, Inc.
COLL
Collegium Pharmaceutical, Inc.
357
#6
Beta Bionics, Inc.
BBNX
Beta Bionics, Inc.
352
#7
Enliven Therapeutics, Inc.
ELVN
Enliven Therapeutics, Inc.
62
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · DVAX peer comparison

About DVAX employees

DVAX Employees · Headcount

Dynavax Technologies Corporation (DVAX) employee data is sourced from the annual SEC 10-K filing. As of 2024, Dynavax Technologies Corporation had 405 full-time employees globally. Full-time employees only. Global consolidated headcount.

Dynavax Technologies Corporation employs 405 full-time employees as of the latest filing within the Drug Manufacturers - Specialty & Generic industry. Revenue per employee stands at $684,558, reflecting the company's operational efficiency.

Dynavax Technologies Corporation's workforce decreased by 3 (0.74%) in 2024 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Dynavax Technologies Corporation's revenue per employee of $684,558 positions it among the notable performers in the Drug Manufacturers - Specialty & Generic sector for operational efficiency.

Frequently Asked Questions

DVAX Employees · 5 questions

As of the latest SEC 10-K filing (2024), Dynavax Technologies Corporation had 405 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Dynavax Technologies Corporation employee counthow many employees does Dynavax Technologies Corporation haveDVAX total employees 2024

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-02-20